Carl Zeiss Meditec AG (XTRA: AFX)
Health Care · Health Care Equipment & Supplies · DE
€32.42
+4.38% today · -26.5% 1Y
Carl Zeiss Meditec AG (XTRA: AFX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $3.18B and employs 5,784 people.
Over the last twelve months the share price has lost 26.5%, trading between 22.62 and 48.36.
Tweenvest scores Carl Zeiss Meditec AG across four factors: quality 75/100, value 71/100, growth 33/100, dividend 31/100. Its strongest factor is quality.
AFX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.18B
- Revenue (TTM)
- $2.49B
- P/E
- 23.25
- EPS
- 1.39
- Dividend yield
- 1.77%
- Beta (5Y)
- 1.33
- 52-week high
- €48.36
- 52-week low
- €22.62
- Avg volume (3M)
- —
- Shares outstanding
- 87.54M
- Employees
- 5,784
- Next earnings
- —
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.
- ISIN
- DE0005313704
- Founded
- 1846
- Listed since
- Mar 22, 2000
- Exchange
- XETRA Trading Platform
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Envista Holdings CorporationNYSE: NVST | $3.69B | $23.00 | +1.23% |
| iRhythm Holdings, Inc.NasdaqGS: IRTC | $3.52B | $106.70 | +4.00% |
| Lepu Medical Technology (Beijing) Co., Ltd.SZSE: 300003 | $3.21B | CN¥11.68 | +1.92% |
| Zhende Medical Co., Ltd.SHSE: 603301 | $3.19B | CN¥81.00 | +7.76% |
| Hangzhou Diagens Biotechnology Co., Ltd.SEHK: 2526 | $3.04B | HK$268.60 | -8.08% |
| Autobio Diagnostics Co., Ltd.SHSE: 603658 | $2.85B | CN¥33.45 | -1.85% |
| Ambu A/SCPSE: AMBU B | $2.85B | Dkr72.85 | +2.97% |
| AtriCure, Inc.NasdaqGM: ATRC | $2.84B | $55.81 | +1.22% |
Figures last refreshed Oct 11, 2026.